Vestibular Evoked Myogenic Potential: A New Device Propose

This study has been completed.
Sponsor:
Collaborators:
Aline Carabl de Oliveira
José Fernando Colafêmina
Information provided by:
Universidade Estadual de Ciências da Saúde de Alagoas
ClinicalTrials.gov Identifier:
NCT01132105
First received: May 26, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
  Purpose

The bioelectrical responses of muscle, evoked by sound, obtained with a device considered the gold standard (widely used in clinics and hospitals) are similar to those obtained with a new device developed


Condition Intervention
Evoked Potentials, Motor, Vestibular
Device: Vestibular myogenic evoked potential analyzer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Vestibular Evoked Myogenic Potential: A New Device Propose

Further study details as provided by Universidade Estadual de Ciências da Saúde de Alagoas:

Groups/Cohorts Assigned Interventions
Normal subjects
Adults normal hearing and vestibular function subjects
Device: Vestibular myogenic evoked potential analyzer

  Eligibility

Ages Eligible for Study:   25 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Adults, Normal Hearing, Normal Vestibular fuction,

Criteria

Inclusion Criteria:

  • hearing thresholds equal to or less than 20 dB HL with differences between the ears, by frequency, equal to or less than 10 dB.

Exclusion Criteria:

  • Occupational noise exposure
  • Ear surgeries
  • More than three ear infections in the current year
  • Use of ototoxic medication
  • Tinnitus, vertigo, dizziness or other vestibular-cochlear diseases
  • Systemic diseases that may contribute to cochlear-vestibular pathologies, such as hypertension and dyslipidemia
  • Hormonal diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01132105

Locations
Brazil
Universidade Estadual de Ciências da Saúde de Alagoas - UNCISAL
Maceió, Alagoas, Brazil, 57010-300
Sponsors and Collaborators
Universidade Estadual de Ciências da Saúde de Alagoas
Aline Carabl de Oliveira
José Fernando Colafêmina
Investigators
Principal Investigator: Pedro L Menezes, PhD Universidade Estadual de Ciências da Saúde de Alagoas
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01132105     History of Changes
Other Study ID Numbers: UNCISAL-PM-001
Study First Received: May 26, 2010
Last Updated: May 26, 2010
Health Authority: Brazil: Ministery of Health

ClinicalTrials.gov processed this record on August 26, 2014